Concepts (338)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastric Bypass | 8 | 2022 | 812 | 1.860 |
Why?
|
| Obesity, Morbid | 5 | 2022 | 1213 | 1.170 |
Why?
|
| Fish Oils | 15 | 2009 | 470 | 1.160 |
Why?
|
| Weight Loss | 11 | 2022 | 2625 | 1.120 |
Why?
|
| S Phase | 8 | 2007 | 423 | 0.960 |
Why?
|
| Weight Gain | 3 | 2021 | 2293 | 0.910 |
Why?
|
| Hyperphagia | 1 | 2021 | 136 | 0.770 |
Why?
|
| Phentermine | 1 | 2020 | 33 | 0.740 |
Why?
|
| Anti-Obesity Agents | 2 | 2021 | 217 | 0.730 |
Why?
|
| Obesity | 15 | 2021 | 12745 | 0.590 |
Why?
|
| Dietary Carbohydrates | 1 | 2021 | 905 | 0.560 |
Why?
|
| Insulin | 11 | 2021 | 6582 | 0.560 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 658 | 0.500 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2016 | 340 | 0.480 |
Why?
|
| Insulin Resistance | 8 | 2021 | 3864 | 0.440 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2017 | 365 | 0.430 |
Why?
|
| Insulin-Secreting Cells | 2 | 2019 | 892 | 0.410 |
Why?
|
| Bariatric Surgery | 1 | 2021 | 952 | 0.380 |
Why?
|
| Fructose | 1 | 2012 | 289 | 0.370 |
Why?
|
| Endocrinology | 1 | 2016 | 443 | 0.360 |
Why?
|
| Intestinal Neoplasms | 1 | 2012 | 319 | 0.360 |
Why?
|
| DNA Replication | 3 | 2002 | 1399 | 0.340 |
Why?
|
| G1 Phase | 3 | 2007 | 415 | 0.330 |
Why?
|
| Muscles | 10 | 1994 | 1614 | 0.330 |
Why?
|
| Glycolysis | 1 | 2012 | 829 | 0.320 |
Why?
|
| Dietary Fats | 8 | 2019 | 2016 | 0.310 |
Why?
|
| Carcinoma 256, Walker | 5 | 1995 | 39 | 0.300 |
Why?
|
| Cell Cycle | 5 | 2001 | 2968 | 0.290 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15295 | 0.280 |
Why?
|
| Lipids | 3 | 2016 | 3307 | 0.260 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 1995 | 4424 | 0.240 |
Why?
|
| Docosahexaenoic Acids | 2 | 2001 | 875 | 0.240 |
Why?
|
| Interleukin-1 | 6 | 1995 | 1263 | 0.230 |
Why?
|
| Electronic Health Records | 1 | 2020 | 4468 | 0.230 |
Why?
|
| Bromodeoxyuridine | 5 | 2002 | 322 | 0.230 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 1995 | 520 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2943 | 0.220 |
Why?
|
| Replication Origin | 1 | 2002 | 77 | 0.220 |
Why?
|
| Endotoxins | 3 | 1995 | 527 | 0.210 |
Why?
|
| Leucine | 11 | 1995 | 560 | 0.210 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2002 | 143 | 0.210 |
Why?
|
| Parenteral Nutrition, Total | 8 | 1995 | 302 | 0.210 |
Why?
|
| Glucose Clamp Technique | 1 | 2021 | 266 | 0.190 |
Why?
|
| Cell Division | 7 | 2002 | 4569 | 0.190 |
Why?
|
| Electron Transport | 1 | 2021 | 211 | 0.190 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.190 |
Why?
|
| Cytoplasm | 2 | 2021 | 1536 | 0.180 |
Why?
|
| Triglycerides | 8 | 2019 | 2453 | 0.180 |
Why?
|
| Flow Cytometry | 8 | 2002 | 5974 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 7281 | 0.170 |
Why?
|
| Rats, Inbred Strains | 15 | 1992 | 2186 | 0.170 |
Why?
|
| Glutathione | 1 | 2021 | 590 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.160 |
Why?
|
| Proteins | 12 | 2017 | 6100 | 0.160 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 671 | 0.150 |
Why?
|
| Protein-Energy Malnutrition | 1 | 2017 | 187 | 0.140 |
Why?
|
| Fungal Proteins | 1 | 2001 | 912 | 0.140 |
Why?
|
| Nutritional Sciences | 1 | 2017 | 137 | 0.140 |
Why?
|
| Glucose | 6 | 2012 | 4398 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2184 | 0.130 |
Why?
|
| Rats | 29 | 1995 | 24252 | 0.130 |
Why?
|
| Postoperative Period | 1 | 2020 | 1842 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5263 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2021 | 2618 | 0.120 |
Why?
|
| Splanchnic Circulation | 2 | 1992 | 110 | 0.120 |
Why?
|
| Documentation | 1 | 2020 | 871 | 0.120 |
Why?
|
| Retrospective Studies | 7 | 2022 | 77459 | 0.120 |
Why?
|
| Humans | 45 | 2022 | 744376 | 0.120 |
Why?
|
| Protein Kinases | 1 | 2001 | 1640 | 0.110 |
Why?
|
| Adult | 24 | 2021 | 214056 | 0.110 |
Why?
|
| Vitamin D | 1 | 2007 | 3224 | 0.110 |
Why?
|
| Female | 25 | 2021 | 380200 | 0.110 |
Why?
|
| Male | 47 | 2021 | 350118 | 0.110 |
Why?
|
| Toxemia | 1 | 1992 | 14 | 0.110 |
Why?
|
| Middle Aged | 13 | 2021 | 213388 | 0.110 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2012 | 55 | 0.110 |
Why?
|
| Corn Oil | 2 | 2002 | 29 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2012 | 124 | 0.110 |
Why?
|
| Neoplasm Proteins | 4 | 1993 | 3706 | 0.110 |
Why?
|
| Dietary Proteins | 5 | 1986 | 963 | 0.100 |
Why?
|
| Safflower Oil | 5 | 1995 | 29 | 0.100 |
Why?
|
| Sarcoma, Experimental | 1 | 1991 | 128 | 0.100 |
Why?
|
| Lactates | 1 | 1992 | 432 | 0.100 |
Why?
|
| Plant Proteins | 2 | 1983 | 364 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2021 | 3280 | 0.100 |
Why?
|
| Zinc | 7 | 1995 | 684 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2016 | 2715 | 0.100 |
Why?
|
| Neoplasm Transplantation | 6 | 1995 | 2086 | 0.100 |
Why?
|
| Time Factors | 10 | 2018 | 40077 | 0.100 |
Why?
|
| Caloric Restriction | 1 | 2013 | 302 | 0.100 |
Why?
|
| Nitrogen | 5 | 1989 | 344 | 0.100 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2002 | 1344 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2001 | 4162 | 0.090 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2013 | 262 | 0.090 |
Why?
|
| Indomethacin | 2 | 2001 | 332 | 0.090 |
Why?
|
| Overweight | 1 | 2021 | 2371 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2016 | 6366 | 0.090 |
Why?
|
| Maternal-Fetal Exchange | 2 | 1989 | 456 | 0.090 |
Why?
|
| Phenylpropanolamine | 1 | 1989 | 15 | 0.090 |
Why?
|
| Muscle Proteins | 3 | 1992 | 1158 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3465 | 0.080 |
Why?
|
| Liver | 13 | 1995 | 7475 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2001 | 5023 | 0.080 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 638 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2016 | 1487 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2001 | 371 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8340 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2542 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 1 | 1989 | 438 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3514 | 0.080 |
Why?
|
| Preoperative Period | 1 | 2010 | 549 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 1991 | 634 | 0.080 |
Why?
|
| Calcitriol | 1 | 2009 | 297 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.080 |
Why?
|
| Adiponectin | 1 | 2013 | 1101 | 0.080 |
Why?
|
| Body Weight | 9 | 2021 | 4671 | 0.080 |
Why?
|
| Sarcoma, Yoshida | 3 | 1992 | 11 | 0.070 |
Why?
|
| Eating | 3 | 2007 | 1536 | 0.070 |
Why?
|
| Brachial Artery | 2 | 2008 | 369 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2019 | 3296 | 0.070 |
Why?
|
| Cholesterol, HDL | 1 | 2013 | 1813 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 1994 | 1904 | 0.070 |
Why?
|
| Pregnancy, Animal | 1 | 1987 | 134 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13035 | 0.070 |
Why?
|
| Joint Diseases | 1 | 2010 | 479 | 0.070 |
Why?
|
| Animals | 37 | 2017 | 168770 | 0.070 |
Why?
|
| Body Mass Index | 5 | 2013 | 12720 | 0.070 |
Why?
|
| Mathematics | 3 | 1994 | 728 | 0.070 |
Why?
|
| Blood Pressure | 3 | 1993 | 8551 | 0.070 |
Why?
|
| Glucose Tolerance Test | 3 | 2019 | 1150 | 0.060 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 16692 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39052 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 9 | 1995 | 8300 | 0.060 |
Why?
|
| Apoptosis | 1 | 2000 | 9726 | 0.060 |
Why?
|
| Kinetics | 9 | 1995 | 6476 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 11126 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6314 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 1992 | 880 | 0.060 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2001 | 546 | 0.060 |
Why?
|
| Risk Factors | 4 | 2021 | 72295 | 0.060 |
Why?
|
| Infusions, Intravenous | 3 | 1994 | 2274 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 9647 | 0.060 |
Why?
|
| Carbon Radioisotopes | 5 | 1991 | 577 | 0.060 |
Why?
|
| Dyslipidemias | 1 | 2010 | 849 | 0.060 |
Why?
|
| Cell Extracts | 1 | 2002 | 138 | 0.050 |
Why?
|
| Cell-Free System | 1 | 2002 | 344 | 0.050 |
Why?
|
| Diet | 7 | 1992 | 7937 | 0.050 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1983 | 370 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3778 | 0.050 |
Why?
|
| Hypertension | 3 | 2010 | 8479 | 0.050 |
Why?
|
| Fasting | 4 | 1995 | 1592 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2012 | 3084 | 0.050 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2000 | 9 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2001 | 142 | 0.050 |
Why?
|
| Transcription Factor DP1 | 1 | 2001 | 141 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2001 | 10943 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4369 | 0.050 |
Why?
|
| Vasodilation | 3 | 2013 | 944 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2001 | 200 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 1 | 2001 | 190 | 0.050 |
Why?
|
| Tritium | 4 | 1995 | 745 | 0.050 |
Why?
|
| Mononuclear Phagocyte System | 2 | 1990 | 56 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2001 | 277 | 0.050 |
Why?
|
| DNA | 5 | 2002 | 7294 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 242 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2010 | 1887 | 0.050 |
Why?
|
| Adenoma, Acidophil | 1 | 1979 | 3 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2000 | 270 | 0.040 |
Why?
|
| CHO Cells | 1 | 2002 | 1409 | 0.040 |
Why?
|
| Bromocriptine | 1 | 1979 | 111 | 0.040 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2005 | 576 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 295 | 0.040 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2001 | 226 | 0.040 |
Why?
|
| Fetus | 1 | 1987 | 1880 | 0.040 |
Why?
|
| Blood Glucose | 7 | 2013 | 6254 | 0.040 |
Why?
|
| Fat Emulsions, Intravenous | 3 | 1992 | 321 | 0.040 |
Why?
|
| Age Factors | 1 | 2016 | 18373 | 0.040 |
Why?
|
| Cricetinae | 1 | 2002 | 2475 | 0.040 |
Why?
|
| Enteral Nutrition | 3 | 1989 | 767 | 0.040 |
Why?
|
| Informed Consent | 1 | 2005 | 995 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2150 | 0.040 |
Why?
|
| DNA, Neoplasm | 2 | 1994 | 1758 | 0.040 |
Why?
|
| Endothelium, Vascular | 2 | 2008 | 4458 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 981 | 0.040 |
Why?
|
| Parenteral Nutrition | 2 | 1995 | 650 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 2 | 1992 | 251 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 663 | 0.040 |
Why?
|
| Body Composition | 2 | 2019 | 2402 | 0.040 |
Why?
|
| Adipokines | 1 | 2019 | 320 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1683 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 959 | 0.040 |
Why?
|
| Cytokines | 1 | 1992 | 7323 | 0.040 |
Why?
|
| Length of Stay | 1 | 2010 | 6311 | 0.040 |
Why?
|
| Deoxyglucose | 2 | 1995 | 337 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 1995 | 2015 | 0.040 |
Why?
|
| Acromegaly | 1 | 1979 | 346 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8432 | 0.030 |
Why?
|
| Fatty Acids | 3 | 2000 | 1809 | 0.030 |
Why?
|
| Cell Count | 1 | 2000 | 1856 | 0.030 |
Why?
|
| Models, Biological | 5 | 1994 | 9584 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2002 | 3130 | 0.030 |
Why?
|
| Rats, Inbred F344 | 2 | 1994 | 862 | 0.030 |
Why?
|
| Comorbidity | 1 | 2010 | 10388 | 0.030 |
Why?
|
| Protein Biosynthesis | 5 | 1992 | 2126 | 0.030 |
Why?
|
| Inflammation | 2 | 2013 | 10636 | 0.030 |
Why?
|
| Absorption | 3 | 1983 | 248 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 2001 | 1073 | 0.030 |
Why?
|
| Young Adult | 1 | 2021 | 56434 | 0.030 |
Why?
|
| Drug Synergism | 2 | 2009 | 1797 | 0.030 |
Why?
|
| Energy Metabolism | 6 | 1995 | 2897 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 2278 | 0.030 |
Why?
|
| Mitotic Index | 1 | 1994 | 172 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1995 | 262 | 0.030 |
Why?
|
| Nutritive Value | 4 | 1983 | 339 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1995 | 1572 | 0.030 |
Why?
|
| Intestinal Absorption | 3 | 1983 | 420 | 0.030 |
Why?
|
| Plant Oils | 2 | 1995 | 202 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4253 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1434 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10484 | 0.030 |
Why?
|
| Prevalence | 1 | 2010 | 15221 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2969 | 0.030 |
Why?
|
| Endothelins | 1 | 1993 | 138 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 3873 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2000 | 3001 | 0.030 |
Why?
|
| Carcinosarcoma | 1 | 1993 | 108 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2000 | 5181 | 0.030 |
Why?
|
| Thromboxane A2 | 1 | 1992 | 93 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1991 | 70 | 0.030 |
Why?
|
| Random Allocation | 3 | 1995 | 2428 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2010 | 5749 | 0.030 |
Why?
|
| Feces | 5 | 1983 | 1401 | 0.030 |
Why?
|
| Zinc Isotopes | 4 | 1983 | 6 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2017 | 1534 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1994 | 1420 | 0.020 |
Why?
|
| Meat | 3 | 1983 | 592 | 0.020 |
Why?
|
| Nutrition Disorders | 1 | 1992 | 211 | 0.020 |
Why?
|
| Floxuridine | 1 | 1991 | 49 | 0.020 |
Why?
|
| Propidium | 1 | 1991 | 41 | 0.020 |
Why?
|
| Antiporters | 1 | 1992 | 277 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2013 | 4196 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 1979 | 1345 | 0.020 |
Why?
|
| G2 Phase | 1 | 1991 | 139 | 0.020 |
Why?
|
| C-Peptide | 1 | 1992 | 419 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1993 | 13695 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5077 | 0.020 |
Why?
|
| Cardiac Output | 1 | 1992 | 854 | 0.020 |
Why?
|
| Litter Size | 1 | 1989 | 54 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2017 | 2740 | 0.020 |
Why?
|
| Systole | 1 | 1992 | 958 | 0.020 |
Why?
|
| Diastole | 1 | 1992 | 791 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2001 | 8437 | 0.020 |
Why?
|
| Gestational Age | 2 | 1989 | 3493 | 0.020 |
Why?
|
| Life Style | 1 | 2021 | 3835 | 0.020 |
Why?
|
| Energy Intake | 4 | 1989 | 2148 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 1350 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 7722 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2022 | 63115 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4554 | 0.020 |
Why?
|
| Arginine | 1 | 1992 | 944 | 0.020 |
Why?
|
| Burns | 2 | 1989 | 1815 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 1993 | 665 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 1992 | 1276 | 0.020 |
Why?
|
| Acute Disease | 1 | 2017 | 7147 | 0.020 |
Why?
|
| Lactic Acid | 1 | 1992 | 1132 | 0.020 |
Why?
|
| Iron | 3 | 1983 | 1774 | 0.020 |
Why?
|
| Neutron Activation Analysis | 2 | 1983 | 35 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2019 | 8319 | 0.020 |
Why?
|
| Waist-Hip Ratio | 1 | 2008 | 517 | 0.020 |
Why?
|
| Milk Proteins | 2 | 1983 | 169 | 0.020 |
Why?
|
| Models, Theoretical | 2 | 1989 | 3589 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1989 | 968 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2008 | 392 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2001 | 19233 | 0.020 |
Why?
|
| MEDLINE | 1 | 2005 | 125 | 0.020 |
Why?
|
| Posture | 1 | 1989 | 958 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1992 | 2455 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2001 | 5535 | 0.020 |
Why?
|
| Egg Proteins | 1 | 1983 | 58 | 0.010 |
Why?
|
| Aged | 4 | 2012 | 163284 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2008 | 1423 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 2005 | 325 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 332 | 0.010 |
Why?
|
| Neoplasms | 1 | 1992 | 21693 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2013 | 2685 | 0.010 |
Why?
|
| Recombinant Proteins | 4 | 1995 | 6621 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1987 | 2327 | 0.010 |
Why?
|
| Amino Acids | 1 | 1988 | 1737 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15159 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2001 | 12209 | 0.010 |
Why?
|
| Selenium | 1 | 1983 | 405 | 0.010 |
Why?
|
| Nitrates | 1 | 1981 | 265 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1995 | 4925 | 0.010 |
Why?
|
| Physical Fitness | 1 | 1983 | 732 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2000 | 23406 | 0.010 |
Why?
|
| Cell Line | 1 | 1991 | 16000 | 0.010 |
Why?
|
| Pregnancy | 2 | 1989 | 29144 | 0.010 |
Why?
|
| Helianthus | 1 | 1995 | 7 | 0.010 |
Why?
|
| Respiration | 2 | 1995 | 1653 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1989 | 12025 | 0.010 |
Why?
|
| United States | 1 | 2022 | 69869 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12244 | 0.010 |
Why?
|
| Sex Factors | 1 | 2008 | 10400 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1991 | 6364 | 0.010 |
Why?
|
| Adolescent | 3 | 1989 | 85784 | 0.010 |
Why?
|
| Organ Size | 2 | 1990 | 2251 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1993 | 919 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2005 | 3610 | 0.010 |
Why?
|
| Emulsions | 1 | 1992 | 156 | 0.010 |
Why?
|
| Calorimetry, Indirect | 1 | 1993 | 183 | 0.010 |
Why?
|
| Oxygen Consumption | 2 | 1989 | 1868 | 0.010 |
Why?
|
| Soybean Oil | 1 | 1992 | 133 | 0.010 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1991 | 63 | 0.010 |
Why?
|
| Chickens | 2 | 1983 | 865 | 0.010 |
Why?
|
| Hormones | 1 | 1995 | 889 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1990 | 419 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 1993 | 415 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1990 | 380 | 0.010 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 1991 | 227 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1991 | 402 | 0.010 |
Why?
|
| Diet, Reducing | 1 | 1992 | 462 | 0.010 |
Why?
|
| Phospholipids | 1 | 1992 | 784 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1988 | 191 | 0.010 |
Why?
|
| Glucagon | 1 | 1990 | 533 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1991 | 1525 | 0.000 |
Why?
|
| Gluconeogenesis | 1 | 1988 | 183 | 0.000 |
Why?
|
| Caseins | 1 | 1986 | 104 | 0.000 |
Why?
|
| Selenious Acid | 1 | 1983 | 6 | 0.000 |
Why?
|
| Isotopes | 1 | 1983 | 124 | 0.000 |
Why?
|
| Reference Values | 1 | 1990 | 4982 | 0.000 |
Why?
|
| RNA | 1 | 1992 | 2749 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2005 | 53291 | 0.000 |
Why?
|
| Gamma Rays | 1 | 1981 | 320 | 0.000 |
Why?
|
| Plasma | 1 | 1981 | 575 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 3922 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 1990 | 57776 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1992 | 40558 | 0.000 |
Why?
|
| Algorithms | 1 | 1988 | 13882 | 0.000 |
Why?
|
Concepts
(338)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_